News

BioM's articles about and for the Bavarian biotechnology sector


Proteintech acquires ChromoTek

Pro­teintech ac­quires the Martin­sried com­pany Chro­moTek, a lead­ing man­u­fac­turer of so-called nanobod­ies. the com­bined com­pan­ies…

Are you a Tech company? Then apply for TechShare until Oct 23!

TechShare is the pre-IPO edu­ca­tion­al train­ing pro­gramme that helps Tech en­tre­pren­eurs to fa­mil­i­ar­ise them­selves with cap­it­al…

Get in touch with partners all over Europe via the new ClusterXchange platform

Cluster­Xchange has gone on­line and is ready for use. Eli­gible SMEs now have the pos­sib­il­ity to get in touch with part­ners all over…

'SMEs Go International' call for applications

The re­launch of the call for ap­plic­a­tions for ‘SMEs Go In­ter­na­tion­al’ Tech­nic­al Assist­ance Fa­cil­ity has been star­ted. The…

SME needs and how clusters can support their scaling-up process

The Peer­2Scale-Health Hand­book out­lines the needs of SMEs and start-ups, and gives ex­amples on how to best sup­port SMEs in scal­ing-up…

Oncology Virtual Partnering - BioM offers 15% discount

BioM is pleased to offer its net­work a 15% dis­count for On­co­logy Vir­tu­al Part­ner­ing on 22-24 Septem­ber 2020, or­gan­ized by Inova…

USD 103,5 million for Immunic

Im­mu­nic Thera­peut­ics, based in Gräfelf­ing near Mu­nich, re­ceives US$ 103.5 mil­lion from a pub­lic of­fer­ing. The com­pany in­tends…

Success for MorphoSys

MorphoSys re­ceived US ap­prov­al for Mon­juvi for the treat­ment of dif­fuse large cell B-cell lymph­oma (DLBCL). In the fu­ture, the…

EUR 10,7 million for Tubulis from Munich

Tubulis has closed a Ser­ies A fin­an­cing round of EUR 10.7 mil­lion. The start-up in­tends to use the funds to ac­cel­er­ate the…

Virtual MedtecLIVE: MedTech community meets online for the first time

MedtecLIVE brings to­geth­er all the play­ers from the med­ic­al tech­no­logy sec­tor, from tra­di­tion­al sup­pli­ers to re­search groups,…

Newsletter

Subscribe

Archive



Publish press release

Would you like to enter or update data?
Request login data


Dr. Georg Kääb
Dr. Georg Kääb

Communications, Managing Director Bavarian Biotech Cluster